Could a new drug shrink fatty livers in people with HIV?
NCT ID NCT07143968
First seen Feb 03, 2026 · Last updated May 21, 2026 · Updated 15 times
Summary
This study tests whether resmetirom, a drug already approved for other liver conditions, can safely reduce liver fat in people with HIV who also have a fatty liver disease called MASLD. About 120 adults with HIV on antiretroviral therapy will take either the drug or a placebo daily for 24 weeks. Researchers will measure liver fat changes using MRI scans and monitor safety through blood tests and check-ups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV (HUMAN IMMUNODEFICIENCY VIRUS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atlantic Clinical Research Institute
NOT_YET_RECRUITINGWest Palm Beach, Florida, 33409, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Duke University Medical Center
NOT_YET_RECRUITINGDurham, North Carolina, 27710, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Indiana University
RECRUITINGIndianapolis, Indiana, 46202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Johns Hopkins University
NOT_YET_RECRUITINGBaltimore, Maryland, 21205, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mt Sinai Health System
NOT_YET_RECRUITINGNew York, New York, 10029, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UC San Diego Altman Clinical and Translational Research Institute
NOT_YET_RECRUITINGLa Jolla, California, 92037, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UT Health Houston
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Alabama Birmingham
NOT_YET_RECRUITINGBirmingham, Alabama, 35294, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of California, San Francisco
NOT_YET_RECRUITINGSan Francisco, California, 94143, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Virginia Commonwealth University
NOT_YET_RECRUITINGRichmond, Virginia, 23298, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.